Show simple item record

dc.contributor.authorQualter, Yvonne M
dc.contributor.authorAllen, Nicholas M
dc.contributor.authorCorcoran, John D
dc.contributor.authorO'Donovan, Donough J
dc.date.accessioned2012-01-31T16:35:30Z
dc.date.available2012-01-31T16:35:30Z
dc.date.issued2012-01-31T16:35:30Z
dc.identifier.citationJ Matern Fetal Neonatal Med. 2011 Feb;24(2):267-70. Epub 2010 May 19.en_GB
dc.identifier.issn1476-4954 (Electronic)en_GB
dc.identifier.issn1476-4954 (Linking)en_GB
dc.identifier.pmid20482289en_GB
dc.identifier.doi10.3109/14767058.2010.484471en_GB
dc.identifier.urihttp://hdl.handle.net/10147/206269
dc.description.abstractOBJECTIVE: Transcutaneous bilirubin (TcB) has the potential to reduce serum bilirubin sampling. During a recent survey on the use of TcB in postnatal units in the Republic of Ireland, we identified that only 58% of the 19 units were using TcB and that only two devices were in use, the BiliChek(R) and JM 103(R). We aimed to evaluate and compare these two devices in a regional postnatal unit. METHODS: To evaluate and compare the accuracy of the BiliChek(R) and JM 103(R), we studied simultaneous TcB and total serum bilirubin (TSB) measurements from a population of jaundiced term and near term infants. We evaluated each device with regard to correlation with TSB and potential to safely reduce serum bilirubin testing. RESULTS: Both TcB devices strongly correlated with TSB (r = 0.88 for BiliChek(R) and r = 0.70 for JM 103(R). The BiliChek(R) and JM 103(R) were accurate up to cut-off values of 200 mumol/L and 180 mumol/L, respectively. Using Bhutani's nomogram, 100% sensitivity was achieved using the 75th percentile for BiliChek(R) and the 40th percentile for JM 103(R). CONCLUSION: Both TcB devices correlated closely with moderately increased TSB levels and are suitable screening tools to identify jaundiced infants that require a serum bilirubin, with upper limit cut-off values. Both devices reduced the need for TSB levels. We found the BiliChek(R) slightly more accurate than the JM 103(R) for our study population. TcB however, is not in widespread use.
dc.language.isoengen_GB
dc.subject.meshBilirubin/*analysis/metabolismen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshGestational Ageen_GB
dc.subject.meshHumansen_GB
dc.subject.meshInfant, Newbornen_GB
dc.subject.meshJaundice, Neonatal/*diagnosis/metabolismen_GB
dc.subject.meshMaleen_GB
dc.subject.meshNeonatal Screening/*instrumentationen_GB
dc.subject.meshNurseries, Hospitalen_GB
dc.subject.meshSensitivity and Specificityen_GB
dc.subject.meshSkin/*chemistry/metabolismen_GB
dc.titleTranscutaneous bilirubin--comparing the accuracy of BiliChek(R) and JM 103(R) in a regional postnatal unit.en_GB
dc.contributor.departmentDepartment of Midwifery, Galway University Hospital, Newcastle Road, Galway,, Ireland. y139q@hotmail.comen_GB
dc.identifier.journalThe journal of maternal-fetal & neonatal medicine : the official journal of the, European Association of Perinatal Medicine, the Federation of Asia and Oceania, Perinatal Societies, the International Society of Perinatal Obstetriciansen_GB
dc.description.provinceConnacht
html.description.abstractOBJECTIVE: Transcutaneous bilirubin (TcB) has the potential to reduce serum bilirubin sampling. During a recent survey on the use of TcB in postnatal units in the Republic of Ireland, we identified that only 58% of the 19 units were using TcB and that only two devices were in use, the BiliChek(R) and JM 103(R). We aimed to evaluate and compare these two devices in a regional postnatal unit. METHODS: To evaluate and compare the accuracy of the BiliChek(R) and JM 103(R), we studied simultaneous TcB and total serum bilirubin (TSB) measurements from a population of jaundiced term and near term infants. We evaluated each device with regard to correlation with TSB and potential to safely reduce serum bilirubin testing. RESULTS: Both TcB devices strongly correlated with TSB (r = 0.88 for BiliChek(R) and r = 0.70 for JM 103(R). The BiliChek(R) and JM 103(R) were accurate up to cut-off values of 200 mumol/L and 180 mumol/L, respectively. Using Bhutani's nomogram, 100% sensitivity was achieved using the 75th percentile for BiliChek(R) and the 40th percentile for JM 103(R). CONCLUSION: Both TcB devices correlated closely with moderately increased TSB levels and are suitable screening tools to identify jaundiced infants that require a serum bilirubin, with upper limit cut-off values. Both devices reduced the need for TSB levels. We found the BiliChek(R) slightly more accurate than the JM 103(R) for our study population. TcB however, is not in widespread use.


This item appears in the following Collection(s)

Show simple item record